ePRIME: Patient-Reported AEs in Early Phase Trials

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

July 30, 2021

Study Completion Date

August 31, 2021

Conditions
Cancer
Interventions
OTHER

ePRIME symptom monitoring tool

ePRIME is an online system for patients to self-report symptoms and AE during cancer treatment. ePRIME allows AE reporting from home or hospital and enables patient reported data to be integrated into existing EPR to allow for the reports to be used in routine care. In addition the system is capable of generating notifications for severe AE to the relevant clinical team and providing patient advice on managing mild and moderate AE.

Trial Locations (2)

LS9 7TF

Leeds Teaching Hospitals NHS Trust, Leeds

Unknown

Weston Park Hospital, Sheffield

All Listed Sponsors
collaborator

Yorkshire Cancer Research

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

lead

University of Leeds

OTHER

NCT03461939 - ePRIME: Patient-Reported AEs in Early Phase Trials | Biotech Hunter | Biotech Hunter